Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02082561 · ClinicalTrials.gov registry record · NA
False Safety Behavior Elimination Therapy: A Randomized Study of a Brief Individual Transdiagnostic Treatment for Anxiety Disorders
A NA study, sponsored by Florida State University.
- Completed
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT02082561 is a NA study that has completed, run by Florida State University. The registered enrollment target is 28 participants.
The verdict
NCT02082561, a NA study, has completed, sponsored by Florida State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The aim of the current study was to test the efficacy of an individually administered, brief (5-session) transdiagnostic treatment for anxiety disorders. The current treatment (called F-SET) focuses chiefly on the elimination of anxiety maintaining behaviors and cognitive strategies (so-called "safety" aids) among individuals suffering from a range of anxiety disorders including generalized anxiety disorder (GAD), social anxiety disorder (SAD) and panic disorder (PD). We hypothesized that the F-SET protocol would produce better overall outcome relative to a waitlist control.
Interventions
- BEHAVIORAL Transdiagnostic Treatment (F-SET)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2010-07 |
| Est. Completion | 2012-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02082561
The ClinicalTrials.gov registry entry for NCT02082561 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Transdiagnostic Treatment (F-SET) is the first listed.
NCT02082561 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02082561 about?
NCT02082561 is a clinical study titled "False Safety Behavior Elimination Therapy: A Randomized Study of a Brief Individual Transdiagnostic Treatment for Anxiety Disorders". The aim of the current study was to test the efficacy of an individually administered, brief (5-session) transdiagnostic treatment for anxiety disorders. The current treatment (called F-SET) focuses chiefly on the elimination of anxiety maintaining behaviors and cognitive strategies (so-called "safe...
What is the current status of trial NCT02082561?
This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2010-07. Estimated completion is 2012-09.
What interventions are being tested in trial NCT02082561?
The interventions under investigation include: Transdiagnostic Treatment (F-SET) (BEHAVIORAL).
Who is sponsoring clinical trial NCT02082561?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.